Navigation Links
Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
Date:5/15/2013

ere were two deaths due to bone marrow failure. For 7 of 13 patients treated with Xofigo bone marrow failure was ongoing at the time of death. Among the 13 patients who experienced bone marrow failure, 54% required blood transfusions. Four percent (4%) of patients in the Xofigo arm and 2% in the placebo arm permanently discontinued therapy due to bone marrow suppression. In the randomized trial, deaths related to vascular hemorrhage in association with myelosuppression were observed in 1% of Xofigo-treated patients compared to 0.3% of patients treated with placebo. The incidence of infection-related deaths (2%), serious infections (10%), and febrile neutropenia (less than 1%) was similar for patients treated with Xofigo and placebo. Myelosuppression –notably thrombocytopenia, neutropenia, pancytopenia, and leukopenia– has been reported in patients treated with Xofigo.

Monitor patients with evidence of compromised bone marrow reserve closely and provide supportive care measures when clinically indicated. Discontinue Xofigo in patients who experience life-threatening complications despite supportive care for bone marrow failure.

Monitor blood counts at baseline and prior to every dose of Xofigo. Prior to first administering Xofigo, the absolute neutrophil count (ANC) should be greater than to equal to 1.5 × 109/L, the platelet count greater than or equal to 100 × 109/L, and hemoglobin greater than or equal to 10 g/dL. Prior to subsequent administrations, the ANC should be greater than or equal to 1 × 109/L and the platelet count greater than or equal to 50 × 109/L. Discontinue Xofigo if hematologic values do not recover within 6 to 8 weeks after the last administration despite receiving supportive care.

Safety and efficacy of concomitant chemotherapy with Xofigo have not been established. Outside of a clinical trial, concomitant use of Xofigo in patients on chemotherapy is
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Bayer Employee Named Rising Star by Healthcare Businesswomens Association
2. Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
3. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
4. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
5. U.S. FDA Grants Priority Review to Bayers Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases
6. Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
7. Bayer Consumer Care Voluntarily Recalls 56 Lots of BRONKAID Caplets Dual Action Formula due to Product Labeling Error
8. Bayers Second Annual Virtual Walk for Hemophilia Raises Funds, Generates Excitement in the Hemophilia Community
9. MediSapiens to Provide Bayer HealthCare Pharmaceuticals With a New Cloud Computing Application to Analyze and Visualize Multi-Dimensional Genomics Data
10. MediSapiens liefert neue Cloud-Computing-App zur Analyse und Visualisierung multidimensionaler Genomdaten an Bayer HealthCare Pharmaceuticals
11. MediSapiens sapprête à fournir à Bayer HealthCare Pharmaceuticals une nouvelle application informatique en nuage pour analyser et visualiser les données génomiques multidimensionnelles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015  China Nepstar Chain Drugstore Ltd. (NYSE: NPD ... chain in China based on ... resignation of Mr. Fuxiang Zhang as the ... Ms. Rebecca Yingnan Zhang has been appointed ... directors, effective immediately. Meanwhile, Ms. Zhang resigned from the ...
(Date:5/21/2015)... 21, 2015  When Ryan Rendino first ... of his neck, he figured it was ... weeks off from weight lifting. ... A series of doctor ... to Michel Kliot, MD , a ...
(Date:5/21/2015)... May 21, 2015 Research ... addition of the "Market Assessment of Respiratory ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... respiratory imaging diagnostics market in the ... . The service provides detailed analysis of ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... Applied Seals North America, Inc. , ... ultraclean manufacturing of nanoelectronics and biomedical products, has ... Silicon Valley headquarters with the hiring of design ... company,s product engineering team to provide additional technical ...
... Pa., Oct. 25 PennDOT and the Pennsylvania State ... influence of prescription and over-the-counter medication can be just ... and illegal drugs. PennDOT will work ... to step up impaired-driving enforcement, with increased emphasis on ...
Cached Medicine Technology:Applied Seals North America Bolsters Engineering and Applications Services in Silicon Valley With Addition of Design Engineer 2PennDOT, State Police Caution Motorists About Dangers of Driving Under Influence of Legal Drugs 2
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 volunteers ... Florida City exactly five years to the day after the ... A large fire tore through the Branches United Methodist Church ... the middle of the night as neighbors, staff and Branches' ... even though it is suspected that the fire began accidentally. ...
(Date:5/23/2015)... CA (PRWEB) May 23, 2015 Dr. David ... California, has just posted a new article to ... repair. As Dr Benvenuti explained in the fascinating ... enlarged plugs in their earlobes. , Known as “gauging,” the ... earlobe hole, which Dr. Benvenuti said will eventually stretch the ...
(Date:5/23/2015)... May 23, 2015 On Wednesday, May ... “the company has been the target of a sophisticated ... of the company’s ongoing Information Technology (IT) security efforts ... , The most notable attack on health insurers ... Inc., the nation’s second largest health insurer, revealed that ...
(Date:5/23/2015)... 2015 Manufacturers are now required to produce ... of 8.2. Experts in the field agree that the regulation ... The HSPF score is what miles per gallon is to ... unit. Although the minimum HSPF score has been raised to ... HSPF score north of 12. Indeed, the regulation was welcomed ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Center, 557 N. Washington St., Janesville, will host an ... pm. , The 8-week clinic is lead by Brent ... who will offer training that encompasses a warm-up, training ... show selection and weekly training plans. , The program ...
Breaking Medicine News(10 mins):Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2
... , Health Sector in Vanguard of Clean Energy Programs ... 3 In recent months, three U.S. hospitals signed energy contracts ... them with up to 10 percent clean energy. The green energy will ... is equivalent to taking 2,052 cars off the road or not burning ...
... PEMBROKE , Bermuda , Feb. 3 ... announced today that Theana Iordanou has,joined the company as ... responsible for managing profit & loss for the New York ... to,expand distribution and manage relationships with the brokerage community in,the ...
... levels of an inflammatory chemokine were significantly elevated ... obese, according to research conducted by scientists at ... They presented their data at the 5th Annual ... Studies have shown that obesity is correlated with ...
... cancer survivors live longer, questions arise about what kind of ... study from Case Western Reserve University,s Mandel School of Applied ... had more health problems as compared to a sample of ... Well-Being in Older Married Female Cancer Survivors," was published as ...
... , , ... Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award ... company to manufacture Active Pharmaceutical Ingredients (APIs). Adhering to Good ... tonnes of API, 8 million laminated aluminum tubes of dermatological ...
... new approach for the care of respiratory diseases report ... associated with improved outcomes in tests on mice with ... human embryonic stem cells (hESCs). Findings by investigators at ... are scheduled to appear in the March issue of ...
Cached Medicine News:Health News:Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change 2Health News:Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change 3Health News:Unique Clean Energy Program Helps Hospitals Buy Clean Energy, Reduce Costs and Counteract Climate Change 4Health News:Allied World Appoints Theana Iordanou Vice President and New York Regional Branch Manager 2Health News:Allied World Appoints Theana Iordanou Vice President and New York Regional Branch Manager 3Health News:Older female cancer survivors have added health issues compared to their counterparts 2Health News:Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company 2Health News:Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company 3Health News:Frost & Sullivan Ghanaian Pharmaceutical Industry Innovation & Advancement Award Conferred on LaGray Chemical Company 4Health News:Experimental stem cell treatment arrests acute lung injury in mice, study shows 2
... Colorimetric Assay of ... and Low Molecular ... substrate CBS 31.39, ... purified bovine ATIII, ...
Substrate Plasma for Factor V Assay by STA© Analyzers. Freeze-dried human plasma, artificially depleted of factor V....
Substrate Plasma for Factor IX Assay by STA© Analyzers. Freeze-dried human plasma from which factor IX has been removed by selective immuno-adsorption....
Substrate Plasma for Factor XII Assay by STA© Analyzers. Freeze-dried human plasma lacking factor XII....
Medicine Products: